{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:28:29Z","timestamp":1788290909458,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hebei Province Medical Applicable Technology Tracking Project","award":["GZ2022019"],"award-info":[{"award-number":["GZ2022019"]}]},{"name":"Hebei Provincial Science and Technology Program","award":["20377714D"],"award-info":[{"award-number":["20377714D"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:p>Recently, evidence has indicated that CTNNB1 is important in a variety of malignancies. However, how CTNNB1 interacts with immune cell infiltration remains to be further investigated. In this study, we focused on the correlations between CTNNB1 and tumorigenesis, tumor progression, mutation, phosphorylation, and prognosis via gene expression profiling interaction analysis; TIMER 2.0, cBioPortal, GTEx, CPTAC, and GEPIA2 database analyses; and R software. CTNNB1 mutations are most found in uterine endometrioid carcinoma and hepatocellular carcinoma. However, no CTNNB1 mutations were found to be associated with a poor prognosis. In addition, CTNNB1 DNA methylation levels were higher in normal tissues than in tumor tissues in cancer except for breast invasive carcinoma, which had higher methylation levels in tumor tissues. The phosphorylation level of the S675 and S191 sites of CTNNB1 was greater in the primary tumor tissues in the clear cell renal cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, pancreatic adenocarcinoma, and breast cancer datasets but not in the glioblastoma multiform dataset. As for, with respect to immune infiltration, CD8\u2005+\u2005T-cell infiltration was negatively correlated with the expression of CTNNB1 in thymoma and uterine corpus endometrial carcinoma. The CTNNB1 level was found to be positively associated with the infiltration index of the corresponding fibroblasts in the TCGA tumors of colon adenocarcinoma, human papillomavirus-negative head and neck squamous cell carcinoma, mesothelioma, testicular germ cell tumor, and thymoma. We also identified the top CTNNB1-correlated genes in the TCGA projects and analyzed the expression correlation between CTNNB1 and selected target genes, including PPP4R2, RHOA, and SPRED1. Additionally, pathway enrichment suggested that NUMB is involved in the Wnt pathway. This study highlights the predictive role of CTNNB1 across cancers, suggesting that CTNNB1 might serve as a potential biomarker for the diagnosis and prognosis evaluation of various malignant tumors.<\/jats:p>","DOI":"10.1097\/md.0000000000040186","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:04:10Z","timestamp":1730736250000},"page":"e40186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Pancancer analysis of the interactions between CTNNB1 and infiltrating immune cell populations"],"prefix":"10.1097","volume":"103","author":[{"given":"Xiaoyuan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2535-9629","authenticated-orcid":false,"given":"Na","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, The Second Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-021-00995-8","article-title":"Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.","volume":"14","author":"Hong","year":"2022","journal-title":"Genome Med"},{"key":"R2-20260804","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.21037\/jgo-21-251","article-title":"The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma.","volume":"12","author":"Xu","year":"2021","journal-title":"J Gastrointestinal Oncol"},{"key":"R3-20260804","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.0906-6705.2003.00083.x","article-title":"Immunomolecular mapping of adherens junction and desmosomal components in normal human epidermis.","volume":"12","author":"Ishiko","year":"2003","journal-title":"Exp Dermatol"},{"key":"R4-20260804","doi-asserted-by":"crossref","first-page":"dev198846","DOI":"10.1242\/dev.198846","article-title":"WNT signaling in pre-granulosa cells is required for ovarian folliculogenesis and female fertility.","volume":"148","author":"Habara","year":"2021","journal-title":"Development (Cambridge, England)"},{"key":"R5-20260804","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1038\/onc.2017.185","article-title":"\u03b2-catenin downregulates Dicer to promote ovarian cancer metastasis.","volume":"36","author":"To","year":"2017","journal-title":"Oncogene"},{"key":"R6-20260804","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/CBM-190640","article-title":"LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt\/\u03b2-catenin pathway.","volume":"28","author":"Miao","year":"2020","journal-title":"Cancer Biomarkers"},{"key":"R7-20260804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20170681","article-title":"Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt\/\u03b2-catenin signaling.","volume":"38","author":"He","year":"2018","journal-title":"Biosci Rep"},{"key":"R8-20260804","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1073\/pnas.1814506116","article-title":"Ovarian insufficiency and CTNNB1 mutations drive malignant transformation of endometrial hyperplasia with altered PTEN\/PI3K activities.","volume":"116","author":"Terakawa","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-20260804","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41388-020-01541-3","article-title":"Synthetic lethality between MyD88 loss and mutations in Wnt\/\u03b2-catenin pathway in intestinal tumor epithelial cells.","volume":"40","author":"Kajino-Sakamoto","year":"2021","journal-title":"Oncogene"},{"key":"R10-20260804","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-021-03733-5","article-title":"SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by \u03b2-catenin and Beclin1\/autophagy signaling in colorectal cancer.","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"Pt A","key":"R11-20260804","doi-asserted-by":"crossref","first-page":"107043","DOI":"10.1016\/j.intimp.2020.107043","article-title":"CTNNB1 mutation suppresses infiltration of immune cells in hepatocellular carcinoma through miRNA-mediated regulation of chemokine expression.","volume":"89","author":"Xiao","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R12-20260804","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/mmr.2021.11975","article-title":"Tumor suppressor role of sFRP\u20114 in hepatocellular carcinoma via the Wnt\/\u03b2\u2011catenin signaling pathway.","volume":"23","author":"Wu","year":"2021","journal-title":"Mol Med Rep"},{"key":"R13-20260804","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/neuonc\/noz154","article-title":"Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.","volume":"22","author":"Surun","year":"2020","journal-title":"Neuro-Oncology"},{"key":"R14-20260804","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","article-title":"EZH2-Mediated primary cilium deconstruction drives metastatic melanoma formation.","volume":"34","author":"Zingg","year":"2018","journal-title":"Cancer cell"},{"key":"R15-20260804","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10799893.2020.1804280","article-title":"miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3.","volume":"41","author":"Zhang","year":"2021","journal-title":"J Recept Signal Transduct Res"},{"key":"R16-20260804","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oftal.2020.11.028","article-title":"CTNNB1 gene mutation associated with neurodevelopmental disorder, microcephaly, and persistence of bilateral hyperplastic primary vitreous: A case report and literature review.","volume":"97","author":"Zuluaga G\u00f3mez","year":"2022","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R17-20260804","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.62504","article-title":"CTNNB1-related neurodevelopmental disorder in a Chinese population: a case series.","volume":"188","author":"Ho","year":"2022","journal-title":"Am J Med Genet A"},{"key":"R18-20260804","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1128\/MCB.25.20.9063-9072.2005","article-title":"Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination.","volume":"25","author":"Hino","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R19-20260804","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jcb.21041","article-title":"cdk5 modulates beta- and delta-catenin\/Pin1 interactions in neuronal cells.","volume":"100","author":"Mu\u00f1oz","year":"2007","journal-title":"J Cell Biochem"},{"key":"R20-20260804","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1101\/gad.1424006","article-title":"Wnt signaling: is the party in the nucleus?","volume":"20","author":"Willert","year":"2006","journal-title":"Genes Development"},{"issue":"Pt 19","key":"R21-20260804","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1242\/jcs.013771","article-title":"Mechanistic insights from structural studies of beta-catenin and its binding partners.","volume":"120","author":"Xu","year":"2007","journal-title":"J Cell Sci"},{"key":"R22-20260804","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1371\/journal.pbio.0000010","article-title":"The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.","volume":"1","author":"Lee","year":"2003","journal-title":"PLoS Biol"},{"key":"R23-20260804","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis.","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"R24-20260804","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1242\/dev.01458","article-title":"Stabilization of beta-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast.","volume":"131","author":"Kemler","year":"2004","journal-title":"Development (Cambridge, England)"},{"key":"R25-20260804","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","article-title":"Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer.","volume":"110","author":"Cheng","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R26-20260804","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-018-1263-9","article-title":"CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt\/\u03b2-catenin signaling via transactivation of GSK-3\u03b2 and Axin2 expression.","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis"},{"key":"R27-20260804","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/15548627.2019.1586250","article-title":"TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1\/\u03b2-catenin degradation and is targeted for GSK3B\/GSK3\u03b2-mediated phosphorylation and degradation.","volume":"15","author":"Wu","year":"2019","journal-title":"Autophagy"},{"key":"R28-20260804","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1.","volume":"38","author":"Wen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R29-20260804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.5056","article-title":"Therapeutic strategies targeting Wnt\/\u03b2\u2011catenin signaling for colorectal cancer (Review).","volume":"49","author":"Ji","year":"2022","journal-title":"Int J Mol Med"},{"key":"R30-20260804","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tox.2013.07.013","article-title":"Wogonin induced G1 cell cycle arrest by regulating Wnt\/\u03b2-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells.","volume":"312","author":"He","year":"2013","journal-title":"Toxicology"},{"key":"R31-20260804","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/bjc.2011.455","article-title":"Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers.","volume":"105","author":"Braicu","year":"2011","journal-title":"Br J Cancer"},{"key":"R32-20260804","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","article-title":"Poly(ADP-ribose) polymerase inhibition: past, present and future.","volume":"19","author":"Curtin","year":"2020","journal-title":"Nat Rev Drug Discovery"},{"key":"R33-20260804","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/or.2015.4421","article-title":"ARID1A gene mutation in ovarian and endometrial cancers (Review).","volume":"35","author":"Takeda","year":"2016","journal-title":"Oncol Rep"},{"key":"R34-20260804","doi-asserted-by":"crossref","first-page":"e0192881","DOI":"10.1371\/journal.pone.0192881","article-title":"The ARID1A, p53 and \u00df-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.","volume":"13","author":"Heckl","year":"2018","journal-title":"PLoS One"},{"key":"R35-20260804","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PAS.0000000000001553","article-title":"CTNNB1 mutations and aberrant \u03b2-Catenin expression in ovarian endometrioid carcinoma: correlation with patient outcome.","volume":"45","author":"Zyla","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R36-20260804","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40246-016-0096-9","article-title":"The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma.","volume":"10","author":"Chang","year":"2016","journal-title":"Hum Genomics"},{"key":"R37-20260804","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2015.11.009","article-title":"Cancer immune contexture and immunotherapy.","volume":"39","author":"Becht","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"R38-20260804","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/cas.14019","article-title":"Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.","volume":"110","author":"Mikami","year":"2019","journal-title":"Cancer Sci"},{"key":"R39-20260804","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms.","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"R40-20260804","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"key":"R41-20260804","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-19-0558","article-title":"Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer.","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R42-20260804","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","article-title":"Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: a review of current evidence.","volume":"25","author":"Klempner","year":"2020","journal-title":"Oncologist"},{"key":"R43-20260804","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann Oncol"},{"key":"R44-20260804","doi-asserted-by":"crossref","first-page":"e1490854","DOI":"10.1080\/2162402X.2018.1490854","article-title":"Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.","volume":"7","author":"Thomas","year":"2018","journal-title":"Oncoimmunology"},{"key":"R45-20260804","doi-asserted-by":"crossref","first-page":"759565","DOI":"10.3389\/fimmu.2021.759565","article-title":"CTNNB1 alternation is a potential biomarker for immunotherapy prognosis in patients with hepatocellular carcinoma.","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"R46-20260804","doi-asserted-by":"crossref","first-page":"e22382","DOI":"10.1016\/j.heliyon.2023.e22382","article-title":"A precise prognostic signature in CTNNB1-mutant hepatocellular carcinoma: Prognosis prediction and precision treatment exploration.","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:01:22Z","timestamp":1785841282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":46,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040186","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}